DT2-SCT

· Global Institute of Stem Cell Therapy and Research

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DT2-SCT, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus [Phase 2]

See pricing